2 strong ASX 200 blue chip shares to build a portfolio around

Building a portfolio? Then take a look at these blue chip options.

| More on:
A group of people in suits watch as a man puts his hand up to take the opportunity.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Having a few ASX 200 blue-chip shares in your portfolio can be a good thing. That's because blue chips tend to be lower-risk options, which makes them a great foundation to build your investment portfolio from.

But which could be top options for a portfolio today? Let's see what analysts are recommending:

Cochlear Limited (ASX: COH)

The first ASX 200 blue-chip share to look at is Cochlear. It is a global leader in the development, manufacture, and distribution of cochlear implantable devices for the hearing impaired.

Thanks to its leadership position, wide distribution network, investment in research and development, and ageing populations, Cochlear has been growing at a solid rate for over a decade.

The good news is that all these factors remain in place today, which bodes well for the next decade.

It is partly for this reason that Goldman Sachs is bullish on the company and is forecasting a net profit after tax CAGR of +15% from FY 2023 to GY 2026.

Its analysts currently have a buy rating and a $280 price target on Cochlear's shares.

REA Group Limited (ASX: REA)

Another blue chip ASX 200 share that could be a buy is REA Group. It is the leading property listings company behind the dominant realestate.com.au website.

Thanks to this dominance, the shift to online listings, and its international expansion, REA Group has also been growing at a solid rate over the last decade.

Once again, Goldman Sachs appears confident this positive form can continue, particularly given its strong pricing power. It said: "We believe REA is among the highest-quality names in our coverage, given it has the highest ability to continue to drive pricing."

In light of this, Goldman has the company on its conviction list with a buy rating and a $175 price target.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear, Goldman Sachs Group, and REA Group. The Motley Fool Australia has recommended Cochlear and REA Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

Three people in a corporate office pour over a tablet, ready to invest.
Blue Chip Shares

Brokers say these 3 ASX 200 blue chip shares are buys in December

Want some blue chips? Then check out these buy-rated shares

Read more »

A young man talks tech on his phone while looking at a laptop. A financial graph is superimposed across the image.
Blue Chip Shares

These ASX 200 blue-chip shares could be buys in December

These blue chips are highly rated for a reason. Here's what analysts are saying.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

These are the best ASX 200 blue-chip shares to buy now: analysts

Analysts are saying very good things about these blue chips. But why?

Read more »

a man looks down at his phone with a look of happy surprise on his face as though he is thrilled with good news.
Blue Chip Shares

Analysts say these world-class ASX 200 blue-chip shares are buys

Analysts think these blue chips would be good additions to your portfolio.

Read more »

Person holding blue chips.
Blue Chip Shares

2 ASX 200 blue-chip shares trading at a 'significant discount'

This fund manager loves the look of these two large stocks.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Blue Chip Shares

'No. 1 in the US': Morgans says buy this ASX 50 share now

Here's what a leading broker is saying about this ASX 50 share this week.

Read more »

Four investors stand in a line holding cash fanned in their hands with thoughtful looks on their faces.
Blue Chip Shares

Should you buy these excellent ASX 200 blue-chip shares in November?

Is now a good time to pick up these big names? Let's find out what analysts are saying.

Read more »

Businessman working and using Digital Tablet new business project finance investment at coffee cafe.
Blue Chip Shares

Brokers say these ASX 200 blue-chip shares are top buys

Analysts are saying good things about these blue chips. But why are they buys?

Read more »